• Applied Use of Losmapimod (GW856553X) in Inflammation Resear

  2026-06-16

  Losmapimod (GW856553X) offers dual-action p38 MAPK inhibition, uniquely enabling both suppression of inflammatory signaling and acceleration of kinase dephosphorylation. This article delivers actionable protocols, troubleshooting tips, and interpretative insights to maximize reproducibility and data quality in hypertension and COPD research workflows.

• Obeticholic Acid (6-ECDCA, INT-747): Reliable FXR Agonist fo

  2026-06-16

  This article provides scenario-driven guidance for laboratory teams applying Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid, 6-ECDCA, INT-747), SKU B4888, in liver fibrosis and hepatic inflammation models. Detailed Q&A blocks address experimental design, protocol optimization, data interpretation, and vendor reliability. Researchers will find evidence-based best practices and direct references to support reproducibility and rigorous assay outcomes using this potent FXR agonist.

• Mono-ADP-Ribosylation as a Degradation Signal: Insights from

  2026-06-15

  This study uncovers how blocking ubiquitin-mediated degradation reveals endogenous mono-ADP-ribosylation (MARylation) as a functional protein degradation signal. By mapping this modification on PARP7 and the aryl hydrocarbon receptor (AHR), the work establishes a mechanistic link between MARylation and proteasomal turnover, with implications for transcriptional regulation and cell signaling.

• Patient-Derived Gastric Cancer Assembloid Models Advance Dru

  2026-06-15

  This study introduces a novel patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, more accurately reflecting the tumor microenvironment and heterogeneity. The approach enables improved investigation of drug resistance mechanisms and supports the development of personalized therapeutic strategies.

• Bazedoxifene Inhibits IL-6/GP130: Repositioning a SERM in Ca

  2026-06-14

  The reference study demonstrates that bazedoxifene, a selective estrogen receptor modulator previously established in osteoporosis therapy, can disrupt IL-6/GP130 signaling and suppress oncogenic pathways in multiple cancer models. These findings highlight bazedoxifene’s translational potential for oncology, providing a new mechanistic rationale for its repurposing in cancer research.

• Two Decades of Toremifene Citrate in Breast Cancer Therapy

  2026-06-13

  This review synthesizes twenty years of clinical and translational research on Toremifene Citrate as an oral selective estrogen receptor modulator for breast cancer. The findings clarify its efficacy, pharmacological distinctions from tamoxifen, and implications for personalized endocrine therapy.

• FK866 (APO866): Optimizing NAMPT Inhibition in AML Research

  2026-06-12

  FK866 (APO866) empowers hematologic cancer and NAD metabolism studies with precise, non-competitive NAMPT inhibition, offering unique selectivity for malignant versus normal cells. This article delivers actionable protocol enhancements, advanced troubleshooting, and real-world workflow guidance for experimental success.

• GW 4869 Hydrochloride Hydrate: Precision in Exosome Inhibiti

  2026-06-12

  GW 4869 (hydrochloride hydrate) offers reliable inhibition of exosome biogenesis, empowering researchers to dissect intercellular communication and vesicle-mediated signaling in regenerative and disease contexts. This guide distills actionable protocol enhancements, advanced use-cases, and expert troubleshooting strategies to maximize data quality and reproducibility.

• GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Modula

  2026-06-11

  This study identifies the CB1-CREB-GLT-1 signaling axis as a critical mediator of neuronal apoptosis and cognitive dysfunction following traumatic brain injury (TBI). Using a selective CB1 antagonist, the authors show that GLT-1 upregulation via CB1 pathway inhibition restores glutamate homeostasis and improves neurological outcomes, highlighting therapeutic implications for TBI intervention.

• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-06-11

  This study reveals how certain kinase inhibitors, by stabilizing specific inactive conformations of p38α MAP kinase, can markedly accelerate its dephosphorylation by the WIP1 phosphatase. The findings highlight a new strategy for enhancing kinase inhibitor selectivity and potency by modulating phosphatase accessibility, which has practical implications for designing next-generation inhibitors in cancer and signaling research.

• Sulfo-Cy5 Carboxylic Acid: Fluorescent Dye for Life Sciences

  2026-06-10

  Sulfo-Cy5 carboxylic acid enables high-fidelity aqueous labeling for advanced protein and peptide studies—its unique hydrophilicity and low self-quenching empower robust fluorescence imaging, even in complex biological systems. This guide unpacks practical protocols, reference-backed optimizations, and troubleshooting strategies to maximize research outcomes with this next-generation fluorescent dye.

• Ibrexafungerp and Caspofungin: Advances Against C. auris Res

  2026-06-10

  Wiederhold et al. provide strong evidence that ibrexafungerp, a triterpenoid antifungal, maintains in vitro and in vivo efficacy against fluconazole-resistant Candida auris, even with delayed treatment. Their findings reinforce the importance of targeting β-(1,3)-D-glucan biosynthesis and inform the use of lipopeptide antifungals like caspofungin in translational research.

• Defining Precision: Triple Color Prestained Protein Marker i

  2026-06-09

  Unlock superior accuracy in SDS-PAGE and Western blotting with the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa). This in-depth guide explores how this triple color protein ladder empowers advanced workflows and resolves critical assay challenges.

• BMS-345541: Unraveling IKK-1/IKK-2 Inhibition in Angiogenesi

  2026-06-09

  Explore the advanced mechanisms and unique applications of BMS-345541, a potent IKK-1/IKK-2 inhibitor, in angiogenesis and inflammation research. This in-depth analysis integrates recent breakthroughs and practical protocol guidance for translational scientists.

• 3-Methyladenine in Neuroinflammation: Precision Autophagy Mo

  2026-06-08

  Explore how 3-Methyladenine enables targeted autophagy inhibition in neuroinflammation and neuropathic pain research. This article uniquely connects 3-MA’s mechanistic role with assay optimization and translational potential, offering new insights for autophagy research.

460 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page